drugmakers Archives | Be Korea-savvy
Drugmakers Introduce AI to Speed Up Development of Coronavirus Cure

Drugmakers Introduce AI to Speed Up Development of Coronavirus Cure

SEOUL, April 2 (Korea Bizwire) — Artificial intelligence (AI), expected to change the paradigm of new drug development, is gaining new attention as it has proven to be very effective in the global battle with the coronavirus. As the world suffers from the spread of COVID-19, the need for speed when it comes to discovering [...]

S. Korean Bio Shares Tumble on Concerns over Drug Trial Failures

S. Korean Bio Shares Tumble on Concerns over Drug Trial Failures

SEOUL, Sept. 1 (Korea Bizwire) — Bio shares on the Korean stock market tumbled this year as investor confidence was hurt by a series of scandals involving major drugmakers, data showed Saturday. The combined market capitalization of 43 pharmaceutical and bio companies listed on the main bourse, the KOSPI, stood at 81.3 trillion won (US$67.2 [...]

Drugmakers’ Technology Exports Reach 5.3 tln Won in 2018

Drugmakers’ Technology Exports Reach 5.3 tln Won in 2018

SEOUL, Jan. 22 (Korea Bizwire) — Exports of drug-manufacturing technologies by South Korean pharmaceutical and bio companies reached nearly 5.3 trillion won (US$4.7 billion) in 2018 thanks to their efforts to tap into overseas markets, government data showed Tuesday. According to the data by the Ministry of Health and Welfare, industry player Yuhan Corp. and [...]

Major Pharmaceuticals Expand R&D Spending in H1

Major Pharmaceuticals Expand R&D Spending in H1

SEOUL, Aug. 16 (Korea Bizwire) — Major South Korean pharmaceutical companies expanded their spending on research and development (R&D) during the first half this year, with Hanmi Pharmaceutical Co. allocating the most, industry data showed Wednesday. According to their semi-annual business reports, 10 out of the 15 drug companies spent more on R&D during the [...]

S. Korean Drug Firms to Spend Big on R&D this Year

S. Korean Drug Firms to Spend Big on R&D this Year

SEOUL, Jan. 21 (Korea Bizwire) – South Korea’s major pharmaceutical companies are poised to sharply expand their spending on research and development (R&D) in 2016, taking a page from Hanmi Pharmaceutical Co.’s aggressive investment that has led to a series of mega-hit licensing deals, industry sources said Thursday. Of the country’s top 10 drug companies [...]